<p>The National Institutes of Health Clinical Center issued a purchase order to Euroimmun US Incorporated on July 12, 2017, for $7,200.00, with a completion date of July 31, 2017. The order is a firm fixed-price commercial purchase with no set-aside designation. Place of performance is Bethesda, Maryland. The source does not specify what diagnostic reagents, test kits, or medical supplies are included in the order.</p>
<p>The NIH Clinical Center awarded a purchase order to Inova Diagnostics, Inc. valued at $95,123.12 on July 5, 2019. The order is firm fixed price with no set-aside. Performance is located in Bethesda, Maryland. The ultimate completion date is June 30, 2020. The opportunity was posted June 14, 2019 with a due date of June 24, 2019.</p>
<p>The NIH Clinical Center awarded a purchase order to Biomerieux Inc. on April 16, 2018, for $9,166.20 with a firm fixed price structure and no set-aside designation. Place of performance is Bethesda, Maryland. The order ceiling is due for ultimate completion on April 17, 2018. The source does not specify the detailed scope of supplies or services being procured under this purchase order.</p>
<p>The National Institutes of Health Clinical Center issued a purchase order to The Binding Site Inc. valued at $9,496.28 on November 15, 2017, with an ultimate completion date of December 1, 2017. The order is a firm fixed-price acquisition with no set-aside designation. Performance occurs in Bethesda, Maryland. The source does not specify the goods or services being procured under this purchase order.</p>
<p>The NIH Clinical Center awarded a purchase order to EMD Millipore Corp on June 26, 2019, with a ceiling value of $19,471.10 for laboratory products and services. Place of performance is Bethesda, Maryland. The order carries firm fixed price terms and has an ultimate completion date of July 5, 2019.</p>
<p>The NIH Clinical Center awarded a purchase order to Illumina, Inc. for $18,430.00 on May 30, 2018, with a completion date of June 24, 2019. Place of performance is Bethesda, Maryland. The order is priced on a firm fixed price basis. No set-aside was used. The source does not specify the items or services procured under this order.</p>
<p>The NIH Clinical Center awarded a purchase order to Immucor Inc. on June 21, 2017, with a ceiling value of $6,035.65 for in vitro diagnostic products and blood banking supplies. Performance is located in Bethesda, Maryland, with an ultimate completion date of July 21, 2017. The order is firm fixed-price with no set-aside designation.</p>
<p>The NIH Clinical Center awarded a purchase order to Immucor Inc. valued at $17,265.27 on July 1, 2019, for in vitro diagnostic products and blood banking supplies. Place of performance is Bethesda, Maryland. The order carries firm fixed-price terms and was completed by July 26, 2019. No set-aside was applied.</p>
<p>The NIH Clinical Center awarded a purchase order to Siemens Healthcare Diagnostics Inc. valued at $18,581.08 on April 4, 2019, with a completion date of July 5, 2019. The order is firm fixed price with no set-aside applied. Performance takes place in Bethesda, Maryland. The purchase order procures diagnostic analyzer reagents and related supplies for clinical laboratory operations at the NIH Clinical Center.</p>
<p>The NIH Clinical Center awarded a purchase order to LGC Clinical Diagnostics Inc. valued at $13,245.00 on March 22, 2018. Work is performed in Bethesda, Maryland. The order is firm fixed price with an ultimate completion date of April 23, 2018. The source does not specify the goods or services procured.</p>